Australia Cuts Baby RSV Hospitalizations 44% in One Year

Thousands of Australian babies are breathing easier this year, thanks to a simple shot their mothers received during pregnancy.

A major new study shows that a vaccination program launched in early 2025 has cut hospital admissions for RSV by 44% in babies under three months old. RSV, or respiratory syncytial virus, is a highly contagious illness that sends about 12,000 Australian infants to the hospital every year, mostly during winter months.

The research tracked data from 13 hospitals across Australia, comparing 2024 numbers with 2025. The results stunned even the researchers. Babies whose mothers got vaccinated during pregnancy were 80% less likely to be hospitalized. Newborns who received a protective antibody treatment after birth showed even better outcomes at 90% less likely to need hospital care.

"I've seen that reduction on the wards, where we're not seeing these babies coming in with bronchiolitis as we did two years ago," said Dr. Ushma Wadia, a paediatrician at The Kids Research Institute Australia who led the study. She described the program's effectiveness over a single season as "amazing."

Perth mother Katryna Cygler didn't hesitate when offered the vaccine during her pregnancy with son Hugo, now nine months old. She had heard difficult stories from friends whose babies ended up hospitalized with the virus. "It was a no-brainer for me really to go ahead and have the vaccine," she said.

RSV spreads easily through droplets and causes most children to catch it at least once before age two. For some babies, it leads to pneumonia or bronchiolitis, requiring intensive care, breathing tubes, and days in the hospital. Parents watching their infant struggle to breathe find it deeply distressing.

The program offers free vaccines to pregnant women between 28 and 36 weeks. Babies who don't receive protection through their mother's pregnancy can get a monoclonal antibody treatment instead. Both options have proven remarkably effective at keeping babies out of hospital beds.

The Ripple Effect

The benefits extend beyond individual families. Fewer sick babies means less strain on pediatric wards during the busy respiratory season that hits every autumn and winter. Hospital beds previously occupied by RSV patients are now available for other children who need them. Resources can be redirected where they're most needed.

Health experts say even greater protection is possible. Professor Terry Nolan, a paediatrician not involved in the study, believes Australia should aim for 95% of infants to be protected through either maternal vaccination or the antibody treatment. "We could possibly even double those impact numbers down the track," he said.

As autumn arrives in Australia and RSV season begins again, parents have powerful new tools to protect their littlest ones. Hugo Cygler is among thousands of babies benefiting from medical advances that weren't available just two years ago.

One simple vaccine is giving families across Australia something precious: peace of mind during their baby's most vulnerable months.

#